CANCER STEM CELL DRUG RESEARCH COOPERATION DEAL
December 1st, 2005
BY KEITH NUTHALLGERMANY'S Artemis Pharmaceuticals has agreed to help Spanish biotechnology company the Centre for Applied Molecular Research Salamanca (CIBASA) market CIBASA's cancer stem cell based 'Oncostem' technology to pharmaceutical manufacturers developing novel anti-cancer therapies. CIBASA has a collection of cancer mouse models that show identical pathology to corresponding human cancers and similar responses to known therapeutic agents. These, said a joint statement, "can be used to test novel cancer agents and validate their ability to treat cancer by ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.